Discover the most talked about and latest scientific content & concepts.

A Ara, RP Love, TB Follack, KA Ahmed, MB Adolph and L Chelico
The APOBEC3 (A3) enzymes, A3G and A3F, are coordinately expressed in CD4+ T cells and can become coencapsidated into HIV-1 virions, primarily in the absence of the viral infectivity factor (Vif). A3F and A3G are deoxycytidine deaminases that inhibit HIV-1 replication by inducing guanine to adenine hypermutation through deamination of cytosine to form uracil in (-)DNA. The effect of the simultaneous presence of both A3G and A3F on HIV-1 restriction ability is not clear. Here, we used a single cycle infectivity assay and biochemical analyses to determine if coencapsidated A3G and A3F differ in their restriction capacity than A3G or A3F alone. Proviral DNA sequencing demonstrated that compared to each A3 alone, A3G and A3F when combined had a coordinate effect on hypermutation. Using size exclusion chromatography, rotational anisotropy, and in vitro deamination assays we demonstrate that A3F promotes A3G deamination activity by forming an A3F/G hetero-oligomer, in the absence of RNA, which is more efficient at deaminating cytosines. Further, A3F caused the accumulation of shorter reverse transcripts due to decreasing reverse transcriptase efficiency, which would leave single-stranded (-)DNA exposed for longer periods of time enabling more deamination events to occur. Although A3G and A3F are known to function alongside each other, these data provide evidence for an A3F/G hetero-oligomeric A3 with unique properties when compared to each individual counterpart.
Facebook likes*
News coverage*
SC clicks
Enzyme, RNA, HIV, APOBEC3G, Cytosine, Viral infectivity factor, Molecular biology, DNA
MeSH headings
comments powered by Disqus

* Data courtesy of